G 
3.44
+0.88%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$3.37bn
FY2019FY2025
Net income
$268.0m
FY2019FY2025
Free cash flow
$134.0m
FY2019FY2025
Shareholders' equity
$6.73bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.37bn | $2.80bn | $2.36bn | $1.43bn | $675.0m | $469.0m | −$845.0m |
| Research and development | $428.0m | $410.0m | $421.0m | $465.0m | $356.0m | $257.0m | $231.0m |
| Operating income | $222.0m | −$55.0m | −$418.0m | −$1.38bn | −$1.85bn | −$1.35bn | −$3.00bn |
| Net income | $268.0m | −$105.0m | −$434.0m | −$1.68bn | −$3.45bn | −$2.61bn | −$3.75bn |
| Diluted earnings per share | 0.06 | -0.02 | -0.11 | -0.44 | -0.92 | -0.80 | -24.33 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $11.98bn | $9.29bn | $8.79bn | $9.17bn | $11.18bn | $5.44bn | $5.02bn |
| Cash and short-term investments | $6.80bn | $5.63bn | $5.04bn | $5.09bn | $8.08bn | $3.30bn | $2.79bn |
| Total liabilities | $5.23bn | $2.94bn | $2.32bn | $2.51bn | $3.16bn | $11.74bn | $9.25bn |
| Debt | $1.87bn | $364.0m | $793.0m | $1.36bn | $2.17bn | $11.02bn | $8.60bn |
| Shareholders' equity | $6.73bn | $6.40bn | $6.45bn | $6.60bn | $8.02bn | −$6.29bn | −$4.29bn |
| Shares outstanding | 4,429m | 4,205m | 3,916m | 3,838m | 3,742m | 3,257m | 154m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | $231.0m | $852.0m | $86.0m | −$798.0m | −$954.0m | −$643.0m | −$2.11bn |
| Capital spending | −$97.0m | −$77.0m | −$71.0m | −$58.0m | −$73.0m | −$40.0m | −$140.0m |
| Free cash flow | $134.0m | $775.0m | $15.0m | −$856.0m | −$1.03bn | −$683.0m | −$2.25bn |
| Dividends paid | — | — | — | −$31.0m | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $997.0m | $955.0m | $906.0m | $873.0m | $819.0m | $773.0m | $764.0m | $716.0m |
| Operating income | $91.0m | $74.0m | $98.0m | $67.0m | $39.0m | $14.0m | $9.0m | −$38.0m |
| Net income | $252.0m | $136.0m | $171.0m | $37.0m | $35.0m | $24.0m | $26.0m | $26.0m |
| Diluted earnings per share | 0.06 | 0.03 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Cash from operations | $89.0m | −$19.0m | $94.0m | −$127.0m | $64.0m | $73.0m | $253.0m | $338.0m |
| Capital spending | −$17.0m | −$10.0m | −$45.0m | −$32.0m | −$13.0m | −$16.0m | −$30.0m | −$36.0m |
| Free cash flow | $72.0m | −$29.0m | $49.0m | −$159.0m | $51.0m | $57.0m | $223.0m | $302.0m |
| Total assets | $13.45bn | $11.70bn | $11.98bn | $11.36bn | $11.14bn | $9.64bn | $9.29bn | $9.18bn |
| Cash and short-term investments | $6.30bn | $6.26bn | $6.80bn | $6.93bn | $6.97bn | $5.88bn | $5.63bn | $5.65bn |
| Debt | $2.03bn | $1.95bn | $1.87bn | $2.14bn | $1.91bn | $385.0m | $239.0m | $328.0m |
| Shareholders' equity | $6.77bn | $6.52bn | $6.73bn | $6.47bn | $6.36bn | $6.48bn | $6.40bn | $6.36bn |
Financial ratios
Data as of 29 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 6.6% | -2.0% | -17.7% | -96.4% | -274.2% | -288.3% |
| Net margin | 8.0% | -3.8% | -18.4% | -117.4% | -511.0% | -556.1% |
| Return on equity | 4.0% | -1.6% | -6.7% | -25.5% | -43.0% | 41.4% |
| Return on assets | 2.2% | -1.1% | -4.9% | -18.4% | -30.9% | -47.9% |
| Free cash flow yield | 2.4% | 7.1% | 1.3% | -6.2% | -7.6% | -6.0% |
| Revenue growth | 20.5% | 18.6% | 64.6% | 112.3% | 43.9% | -155.5% |
| Earnings growth | -355.2% | -75.8% | -74.2% | -51.2% | 32.2% | -30.4% |
| Current ratio | 1.75x | 2.53x | 3.90x | 5.19x | 8.46x | 4.49x |
| Debt to equity | 0.28x | 0.04x | 0.10x | 0.21x | 0.26x | -0.04x |
| Equity ratio | 56.1% | 68.8% | 73.4% | 72.0% | 71.7% | -115.7% |
| Interest coverage | 3.13x | -1.34x | -4.22x | -8.37x | -1.09x | -0.91x |
| R&D as a share of sales | 12.7% | 14.7% | 17.8% | 32.4% | 52.7% | 54.8% |
| Buybacks as a share of market value | -5.3% | -7.4% | -2.0% | -2.6% | -14.9% | -2014.9% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 33.0% | 48.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 2.7% | -16.4% | -43.5% | — |
| Net margin | 2.6% | -19.6% | -72.2% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 82.5 | -189.0 | -30.4 | -7.3 | -4.8 | -10.1 |
| Price to sales | 6.6 | 7.1 | 5.6 | 8.6 | 24.8 | 56.0 |
Market value over time
31 Dec 2020 to 28 Sept 2026, in USD
$167.2m$12.90bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Return | 0% | 51% | 8% | -34% | -46% | 13% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.